Alzamend Neuro Stock (NASDAQ: ALZN) stock price, news, charts, stock research, profile.
Open | $0.635 |
Close | $0.634 |
Volume / Avg. | 32.280K / 80.925K |
Day Range | 0.600 - 0.679 |
52 Wk Range | 0.439 - 11.910 |
Market Cap | $4.575M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 0.44% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alzamend Neuro (NASDAQ: ALZN) through any online brokerage.
Other companies in Alzamend Neuro’s space includes: Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Alzamend Neuro (NASDAQ: ALZN) was reported by Maxim Group on Wednesday, April 12, 2023. The analyst firm set a price target for 1.50 expecting ALZN to rise to within 12 months (a possible 125.56% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $0.665 last updated May 17, 2024 at 7:32 PM EDT.
There are no upcoming dividends for Alzamend Neuro.
Alzamend Neuro’s Q4 earnings are confirmed for Thursday, July 25, 2024.
There is no upcoming split for Alzamend Neuro.
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.